Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy.
- DOI
- 10.1016/j.antiviral.2026.106489
- Published
- 2026 Sep
- Container
- Antiviral research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.antiviral.2026.106489,
title = {Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy.},
author = {Mhlanga A and Shekhtman L and Cotler SJ and Wasserman O and Degasperi E and Anolli MP and Uceda Renteria SC and Sambarino D and Borghi M and Perbellini R and Facchetti F and Callegaro A and Dahari H and Lampertico P},
year = {2026},
journal = {Antiviral research},
doi = {10.1016/j.antiviral.2026.106489},
url = {https://doi.org/10.1016/j.antiviral.2026.106489}
}RIS
TY - JOUR TI - Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy. AU - Mhlanga A AU - Shekhtman L AU - Cotler SJ AU - Wasserman O AU - Degasperi E AU - Anolli MP AU - Uceda Renteria SC AU - Sambarino D AU - Borghi M AU - Perbellini R AU - Facchetti F AU - Callegaro A AU - Dahari H AU - Lampertico P PY - 2026 JO - Antiviral research DO - 10.1016/j.antiviral.2026.106489 UR - https://doi.org/10.1016/j.antiviral.2026.106489 ER -
APA
A, M., L, S., SJ, C., O, W., E, D., MP, A., SC, U. R., D, S., M, B., R, P., F, F., A, C., H, D., & P, L. (2026). Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy.. Antiviral research. https://doi.org/10.1016/j.antiviral.2026.106489
Source records
- pubmed · retrieved 2026-09-26T04:02:55.561Z